APA

Hall A. B., Newsome D., Wang Y., Boucher D. M., Eustace B., Gu Y., Hare B., Johnson M. A., Milton S., Murphy C. E., Takemoto D., Tolman C., Wood M., Charlton P., Charrier J., Furey B., Golec J., Reaper P. M. & Pollard J. R. (20150605). Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. : Oncotarget.

Chicago

Hall Amy B, Newsome Dave, Wang Yuxin, Boucher Diane M, Eustace Brenda, Gu Yong, Hare Brian, Johnson Mac A, Milton Sean, Murphy Cheryl E, Takemoto Darin, Tolman Crystal, Wood Mark, Charlton Peter, Charrier Jean-Damien, Furey Brinley, Golec Julian, Reaper Philip M and Pollard John R. 20150605. Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. : Oncotarget.

Harvard

Hall A. B., Newsome D., Wang Y., Boucher D. M., Eustace B., Gu Y., Hare B., Johnson M. A., Milton S., Murphy C. E., Takemoto D., Tolman C., Wood M., Charlton P., Charrier J., Furey B., Golec J., Reaper P. M. and Pollard J. R. (20150605). Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. : Oncotarget.

MLA

Hall Amy B, Newsome Dave, Wang Yuxin, Boucher Diane M, Eustace Brenda, Gu Yong, Hare Brian, Johnson Mac A, Milton Sean, Murphy Cheryl E, Takemoto Darin, Tolman Crystal, Wood Mark, Charlton Peter, Charrier Jean-Damien, Furey Brinley, Golec Julian, Reaper Philip M and Pollard John R. Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. : Oncotarget. 20150605.